Get started
Author

Gerrina Ruiter

Observed names: G Ruiter, G. Ruiter, Ruiter, G.
Observed institutions: The Netherlands Cancer Institute, Hospital Universitari i Politècnic La Fe, Amsterdam University Medical Centers, Amsterdam Cardiovascular Sciences, Vrije Universiteit Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam
ORCID: 0009-0003-1668-8559
Observed ORCID: 0009-0003-1668-8559
OpenAlex ID: A5113579080
Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension
2012 · Frances S. de Man, Ly Tu, et al. · American Journal of Respiratory and Critical Care Medicine · 346
PDF
Iron deficiency is common in idiopathic pulmonary arterial hypertension
2010 · G. Ruiter, S. Lankhorst, et al. · European Respiratory Journal · 212
PDF
Intravenous Iron Therapy in Patients with Idiopathic Pulmonary Arterial Hypertension and Iron Deficiency
2015 · Gerrina Ruiter, Emmy Manders, et al. · Pulmonary Circulation · 107
PDF
Right Ventricular Failure in Idiopathic Pulmonary Arterial Hypertension Is Associated With Inefficient Myocardial Oxygen Utilization
2011 · Yeun Ying Wong, Gerrina Ruiter, et al. · Circulation Heart Failure · 80
PDF
Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension
2013 · G. Ruiter, I. J. Lanser, et al. · Lara D. Veeken · 73
Right ventricular oxygen supply parameters are decreased in human and experimental pulmonary hypertension
2012 · Gerrina Ruiter, Yeun Ying Wong, et al. · The Journal of Heart and Lung Transplantation · 54
Copper Dependence of Angioproliferation in Pulmonary Arterial Hypertension in Rats and Humans
2011 · Harm J. Bogaard, Shiro Mizuno, et al. · American Journal of Respiratory Cell and Molecular Biology · 52
Systolic Pulmonary Artery Pressure and Heart Rate are Main Determinants of Oxygen Consumption in the Right Ventricular Myocardium of Patients with Idiopathic Pulmonary Arterial Hypertension
2011 · Yeun Ying Wong, Nico Westerhof, et al. · European Journal of Heart Failure · 42
PDF
Reversibility of the monocrotaline pulmonary hypertension rat model
2013 · Gerrina Ruiter, Frances S. de Man, et al. · European Respiratory Journal · 35
Quality of Life in Patients Treated with First-Line Antiretroviral Therapy Containing Nevirapine And/Or Efavirenz
2004 · the 2NN study group, Frank van Leth, et al. · Antiviral Therapy · 27
PDF
Malnutrition in pulmonary arterial hypertension
2019 · Chermaine T. Kwant, Gerrina Ruiter, et al. · Current Opinion in Pulmonary Medicine · 25
Quadriceps muscle fibre dysfunction in patients with pulmonary arterial hypertension
2015 · Emmy Manders, Gerrina Ruiter, et al. · European Respiratory Journal · 24
PDF
11C-Acetate Clearance as an Index of Oxygen Consumption of the Right Myocardium in Idiopathic Pulmonary Arterial Hypertension: A Validation Study Using 15O-Labeled Tracers and PET
2013 · Yeun Ying Wong, Pieter Raijmakers, et al. · Journal of Nuclear Medicine · 20
PDF
Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non–Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab
2025 · Zofia Piotrowska, Antonio Passaro, et al. · Journal of Clinical Oncology · 18
Pulmonary 2‐Deoxy‐2‐[18F]‐Fluoro‐D‐Glucose Uptake is Low in Treated Patients with Idiopathic Pulmonary Arterial Hypertension
2013 · Gerrina Ruiter, Yeun Ying Wong, et al. · Pulmonary Circulation · 18
Supine-exercise-induced oxygen supply to the right myocardium is attenuated in patients with severe idiopathic pulmonary arterial hypertension
2011 · Yeun Ying Wong, Pieter G Raijmakers, et al. · Heart · 14
Trastuzumab Deruxtecan in Patients With HER2-Overexpressing NSCLC: Results From Part 1 of the Open-Label, Multicenter, Phase 1b DESTINY-Lung03 Trial
2025 · David Planchard, Hye Ryun Kim, et al. · Journal of Thoracic Oncology · 10
1254MO Safety and anti-tumour activity of zipalertinib in NSCLC patients (pts) with EGFR exon 20 insertion (ex20ins) mutations who received prior amivantamab
2024 · A. Passaro, H.A. Yu, et al. · Annals of Oncology · 8
PDF
The interventricular septum in pulmonary hypertension does not show features of right ventricular failure
2014 · Gerrina Ruiter, Mariëlle C. van de Veerdonk, et al. · International Journal of Cardiology · 3
Efficacy of zipalertinib in NSCLC patients with EGFR exon 20 insertion mutations who received prior platinum-based chemotherapy with or without amivantamab.
2025 · Helena Alexandra Yu, Danny Nguyen, et al. · Journal of Clinical Oncology · 2
The Therapeutic Potential Of The Renin-Angiotensin-Aldosteron System In Idiopathic Pulmonary Arterial Hypertension
2012 · Frances de Man, Christophe Guignabert, et al. · 2
Emerging treatment strategies for HER2-mutant NSCLC: Striving for selectivity, efficacy, and tolerability
2026 · Gerrina Ruiter, Xiuning Le, et al. · Lung Cancer · 1
MA08.02 Zipalertinib in NSCLC Patients (Pts) With EGFR Exon 20 Insertion (Ex20Ins) Mutations Who Received Prior Amivantamab
2025 · Z. Piotrowska, D. Nguyen, et al. · Journal of Thoracic Oncology · 1
P3.18.68 First-In-Human Trial of PFL-241/STX-241 in Patients With Locally Advanced or Metastatic NSCLC Resistant to EGFR Tyrosine Kinase Inhibitors
2025 · G. Ruiter, M.L. Johnson, et al. · Journal of Thoracic Oncology · 1
1978P Personalized osimertinib dose frequency adjustment and pharmacokinetic boosting to improve cost-effectiveness in advanced epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC) treatment: OSIBOOST-2A study
2025 · P.D. Kruithof, B.J. Sikkema, et al. · Annals of Oncology · 1
Works count: 42
Citation count: 1,179
H-index: 15
I10-index: 17
Year
Topic
Type